Skip to main content

Table 2 In-hospital therapy and at discharge in patients with or without stroke

From: Immediate and one-year outcome of patients presenting with Acute Coronary Syndrome complicated by stroke: Findings from the 2ndGulf Registry of Acute Coronary Events (Gulf RACE-2)

 

During admission

At discharge

No stroke

Stroke

P value

No stroke

Stroke

P value

(n = 7,874)

(n = 56)

(n = 78744)

(n = 56)

Coronary angiography

32.6%

12.5%*

0.002

   

Percutaneous coronary intervention

14.5%

5.4%

0.08

   

Elective

10.2%

1.8%

0.42

   

Urgent/Emergency PCI (UA/NSTEMI)

4.2%

3.6%

    

Aspirin

98%

91%

0.001

93%

57%

0.001

β blockers

75%

46%

0.001

80%

38%

0.001

Clopidogrel

76%

55%

0.001

68%

38%

0.001

ACE inhibitors

25.6%

33.9%

0.16

72%

47%

0.001

Angiotensin receptor blockers

4.7%

1.8%

0.30

6.8%

1.8%

0.1

HMG-CoA reductase inhibitor

95%

89%

0.06

92%

58%

0.001

GPIIb/IIa inhibitors

7.8%

3.6%

0.25

   

Thrombolytic therapy

      

t-PA

3%

13%

0.09

   

Streoptkinase

42%

40%

    

Reteplase

44%

47%

    

Tenektopase

11%

0%

    

Unfractionated heparin

49.5%

33.9%

0.02

   

LMWH (enoxaparin)

39.1%

21.4%

0.02

   
  1. Data are expressed as percentage; STEMI = ST elevation myocardial infarction; NSTEMI = non ST elevation myocardial infarction; UA = unstable angina; LBBB = left bundle branch block; PCI = percutaneous coronary intervention; LVEF = left ventricular ejection fraction.